- Home
- AER vs PODD Comparison
AER vs PODD Comparison
Compare AER & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AER
- PODD
- Stock Information
- Founded
- AER 1995
- PODD 2000
- Country
- AER Ireland
- PODD United States
- Employees
- AER N/A
- PODD N/A
- Industry
- AER Diversified Commercial Services
- PODD Medical/Dental Instruments
- Sector
- AER Consumer Discretionary
- PODD Health Care
- Exchange
- AER Nasdaq
- PODD Nasdaq
- Market Cap
- AER 20.2B
- PODD 16.5B
- IPO Year
- AER 2006
- PODD 2007
- Fundamental
- Price
- AER $101.61
- PODD $283.48
- Analyst Decision
- AER Strong Buy
- PODD Buy
- Analyst Count
- AER 10
- PODD 16
- Target Price
- AER $110.50
- PODD $291.81
- AVG Volume (30 Days)
- AER 1.2M
- PODD 591.5K
- Earning Date
- AER 02-26-2025
- PODD 02-20-2025
- Dividend Yield
- AER 0.74%
- PODD N/A
- EPS Growth
- AER 19.27
- PODD 96.55
- EPS
- AER 12.74
- PODD 5.78
- Revenue
- AER $7,817,256,000.00
- PODD $2,071,600,000.00
- Revenue This Year
- AER $5.29
- PODD $19.52
- Revenue Next Year
- AER $2.52
- PODD $17.21
- P/E Ratio
- AER $7.98
- PODD $49.12
- Revenue Growth
- AER 4.50
- PODD 22.07
- 52 Week Low
- AER $75.96
- PODD $160.19
- 52 Week High
- AER $107.36
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- AER 59.92
- PODD 55.75
- Support Level
- AER $100.25
- PODD $274.87
- Resistance Level
- AER $107.36
- PODD $288.95
- Average True Range (ATR)
- AER 2.29
- PODD 6.73
- MACD
- AER 0.54
- PODD -0.39
- Stochastic Oscillator
- AER 56.83
- PODD 69.27
About AER AerCap Holdings N.V.
AerCap Holdings NV is an aircraft leasing company. Its major activities include leasing, financing, sales, and management of commercial aircraft and engines. It also provides aircraft asset management and corporate services to securitization vehicles, joint ventures, and other third parties. Through its subsidiary, the group also provides engine leasing, certified aircraft engines, airframes, and engine parts. Its geographical segments include China, United States, and Other countries.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.